Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), continues to develop its innovative powder-based drug delivery technology AmorphOX to improve ...

Nottingham hospital bosses have pledged not to cancel any scheduled operations due to winter pressures which have begun to ...

FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review has been granted in ...